Collegium Pharmaceutical, Inc. - Common Stock —— 现金流量表 (NASDAQ:COLL) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 93.94 M103.56 M124.23 M274.75 M204.98 M329.32 M 331.04 M 投资活动产生的现金 -373.77 M-1.94 M-573.69 M-70.81 M-287.76 M-63.53 M -52.23 M 融资活动产生的现金 286.47 M-89.3 M436.72 M-140.18 M-60.6 M-110.25 M -106.35 M 自由现金流 93.94 M103.56 M124.23 M274.75 M204.98 M327.58 M 329.83 M

新闻

Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to Decline

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium PharmaceuticalQ4每股收益及营收逊于预期

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates